全文获取类型
收费全文 | 86572篇 |
免费 | 9627篇 |
国内免费 | 3213篇 |
专业分类
耳鼻咽喉 | 368篇 |
儿科学 | 1716篇 |
妇产科学 | 960篇 |
基础医学 | 10985篇 |
口腔科学 | 570篇 |
临床医学 | 6839篇 |
内科学 | 13154篇 |
皮肤病学 | 755篇 |
神经病学 | 2443篇 |
特种医学 | 2882篇 |
外国民族医学 | 96篇 |
外科学 | 8409篇 |
综合类 | 14816篇 |
现状与发展 | 11篇 |
预防医学 | 3828篇 |
眼科学 | 390篇 |
药学 | 8832篇 |
42篇 | |
中国医学 | 3649篇 |
肿瘤学 | 18667篇 |
出版年
2024年 | 193篇 |
2023年 | 1185篇 |
2022年 | 2376篇 |
2021年 | 3585篇 |
2020年 | 3157篇 |
2019年 | 2931篇 |
2018年 | 2764篇 |
2017年 | 3219篇 |
2016年 | 3601篇 |
2015年 | 3666篇 |
2014年 | 5664篇 |
2013年 | 5832篇 |
2012年 | 5396篇 |
2011年 | 6178篇 |
2010年 | 4990篇 |
2009年 | 4850篇 |
2008年 | 4866篇 |
2007年 | 5199篇 |
2006年 | 4744篇 |
2005年 | 4209篇 |
2004年 | 3453篇 |
2003年 | 2897篇 |
2002年 | 2255篇 |
2001年 | 1955篇 |
2000年 | 1663篇 |
1999年 | 1265篇 |
1998年 | 1005篇 |
1997年 | 878篇 |
1996年 | 687篇 |
1995年 | 533篇 |
1994年 | 474篇 |
1993年 | 339篇 |
1992年 | 341篇 |
1991年 | 276篇 |
1990年 | 240篇 |
1989年 | 195篇 |
1988年 | 196篇 |
1987年 | 165篇 |
1986年 | 144篇 |
1985年 | 228篇 |
1984年 | 259篇 |
1983年 | 202篇 |
1982年 | 234篇 |
1981年 | 195篇 |
1980年 | 167篇 |
1979年 | 160篇 |
1978年 | 98篇 |
1977年 | 78篇 |
1976年 | 60篇 |
1975年 | 73篇 |
排序方式: 共有10000条查询结果,搜索用时 609 毫秒
131.
目的研究非小细胞肺癌(NSCLC)患者行PET和CT检查的成本效益比,寻找更低成本效益比的检查.方法采用决策分析法,对国内现有NSCLC患者PET及CT诊断效率研究中的数据进行分析,比较其正确检出费用、正确分期费用和正确治疗费用.结果①就检出率而言,CT的成本效益比更低;②就分期准确性而言,CT的成本效益比仍较PET低;③就诊疗费用的成本效益比而言,PET较CT为低;④PET与CT相比,其优势在于诊断Ⅰ期的患者.结论CT适合NSCLC的筛选,而PET适用于临床分期,指导临床治疗. 相似文献
132.
泰素蒂加顺铂治疗进展期NSCLC的临床研究 总被引:5,自引:0,他引:5
目的观察泰素蒂加顺铂方案治疗进展期非小细胞肺癌的临床疗效、毒副作用。方法收集可评价疗效的进展期非小细胞肺癌50例,以泰素蒂加顺铂方案进行化疗,泰素蒂75 mg/m2静脉滴注,第1天;顺铂25 mg/m2~30 mg/m2静脉滴注,第2天~第5天,每3周为一个周期,2~3周期后评价疗效和毒副反应并随访。结果50例患者中,总有效率为50.0 %,其中初治病例为53.1 %,复治病例为44.4 %,初复治病例间差异无显著性(P >0.05)。中位缓解期为5个月。中位生存期为9.5个月,1年生存率为61.0 %。毒副反应主要为骨髓抑制,白细胞下降达Ⅲ度、Ⅳ度者52.0 %,血小板下降达Ⅲ度、Ⅳ度者为14.0 %。血红蛋白下降不严重。其他毒副反应还有脱发、过敏反应、水钠潴留、静脉炎、末梢神经炎、口腔炎、腹泻等,但发生率均较低。结论泰素蒂加顺铂方案治疗进展期非小细胞肺癌,特别是复发病例,临床疗效比较满意,毒副反应能够耐受。辅以G蛳CSF可防治重度的骨髓抑制,有较好的临床应用价值。 相似文献
133.
In Vivo Molecular Imaging Characterizes Pulmonary Gene Expression During Experimental Lung Transplantation 总被引:2,自引:0,他引:2
Sekhar Dharmarajan Makio Hayama James Kozlowski Takaaki Ishiyama Mikio Okazaki Phillip Factor G. Alexander Patterson Daniel P. Schuster 《American journal of transplantation》2005,5(6):1216-1225
Experimental gene therapy is a promising strategy to prevent ischemia-reperfusion (I/R) injury and allograft rejection after lung transplantation, and methods will eventually be needed to characterize pulmonary transgene expression in vivo in humans. Therefore, we studied positron emission tomography (PET) as a means of performing in vivo molecular imaging in rodent models of lung transplantation. Rats were transfected endotracheally with adenovirus encoding a fusion gene of a mutant Herpes simplex virus-1 thymidine kinase and the green fluorescent protein gene (the former serving as an imaging reporter gene). Twenty-four hours after transfection, lungs were transplanted in groups representing normal transplantation, I/R injury and acute allograft rejection. Imaging was obtained either 24 h after transplantation to study reperfusion injury or 4 days after transplantation to study graft rejection. After imaging, lungs were excised and analyzed for thymidine kinase activity. Imaging detected transgene expression in transplanted lungs even in the presence of acute rejection or I/R injury. The PET imaging signal correlated with in vitro lung tissue assays of thymidine kinase activity (r(2) = 0.534). Thus, noninvasive molecular imaging with PET is a feasible, sensitive and quantitative method for characterizing pulmonary transgene expression in experimental lung transplantation. 相似文献
134.
135.
Wing‐Hong Li Moon‐Tong Cheung Candace N.S. Ho Ting‐Pong Fung Kai‐Ming Ko Kelvin K.W. Yau 《Surgical Practice》2007,11(4):138-143
Aim: To examine the survival benefit of liver and lung resection for colorectal metastasis and the potential prognostic factors that affect patient survival. Methods: All patients who had resection of lung or liver metastasis for colorectal metastasis in Queen Elizabeth Hospital, Hong Kong from 1995 to 2004 were retrospectively reviewed. The overall and disease‐free survival was analysed, in particularly between liver and lung metastasis. All factors that may have affected the survival were entered into Cox's proportional hazards regression model to identify significant variables associated with survival. Results: At 5 years, the overall survival of patients who had resection of lung and liver metastasis was 44% and 38%, respectively; the disease‐free survival was 26% and 24%, respectively. Overall and disease‐free survival of patients with resection of lung metastasis was comparable to those with resection of liver metastasis. The differentiations of primary tumour and time to metastasis were shown to be significant prognostic factors influencing overall survival. Those patients with systemic chemotherapy after resection of colorectal metastasis demonstrated a significantly higher probability of overall survival. Conclusion: Resection of lung and liver metastases from colorectal origin was safe and both procedures improved survival. The use of chemotherapy after resection of metastasis significantly improved the overall survival. 相似文献
136.
蛋白酶激活受体1介导人肺上皮细胞分泌白细胞介素-8 总被引:1,自引:0,他引:1
目的探讨蛋白酶激活受体1(PAR1)激动肽和凝血酶对人肺上皮细胞白细胞介索-8(IL-8)分泌的影响。方法人肺上皮细胞系A549细胞分别接种于12孔培养板各孔内,并分别用不同浓度的PAR1激动肽SFLLR和反PAR1激动肽RLLFS以及不同浓度的凝血酶和/或凝血酶抑制剂水蛭索进行刺激,刺激时间为2和16h。用ELISA方法检测上清液中的IL-8水平。结果经过16h的培养,SFLLR可引起浓度相关性IL-8的释放增加,增加到300μmol/L时诱导IL-8的释放量比基础分泌量增加了近16倍,RLLFS不能引起IL-8的释放增加。凝血酶也可引起浓度相关性IL-8释放.凝血酶在浓度1kU/L时就可引起IL-8释放量增加,10kU/L时诱导IL-8释放量达高峰,为基础分泌量的7.5倍。水蛭索可以抑制凝血酶对IL-8的释放作用。时间相关曲线表明,PAR1介导的IL-8释放从2h起即可引起增加,16h达高峰。结论PAR1激动肽和凝血酶可促进人肺上皮细胞分泌IL-8,PAR1拮抗剂和凝血酶抑制剂可能具有抗炎作用。 相似文献
137.
要使疾病相关分组系统在我国尽快推广使用就要提高ICD-10编码的准确率,编码人员必须加强临床医学知识的学习,结合ICD-10的编码原则,通过认真阅读病历再进行编码,临床医师也应了解ICD-10的分类轴心和规则,书写好病历. 相似文献
138.
139.
肿瘤坏死因子及中性粒细胞在脊髓继发性损伤中的作用 总被引:2,自引:0,他引:2
目的 探讨炎性反应对脊髓损伤细胞凋亡的影响及其作用机制。方法 健康Wistar大鼠48只。随机分为2组,实验组与对照组。采用Allen法挫伤大鼠T10节段脊髓,于术后1、8h和1、2、3、7d取材。检测肿瘤坏死因子(TNF)与髓过氧化物酶水平的变化。结果 实验组肿瘤坏死因子与髓过氧化物酶水平均明显升高(P〈0.01)。结论 中性粒细胞及TNF-α参与了脊髓继发性损伤,并可能是触发迟发性神经元凋亡的重要因素之一。 相似文献
140.
Densities in dependent lung regions during anaesthesia: atelectasis or fluid accumulation? 总被引:2,自引:0,他引:2
Å. Strandberg G. Hedenstierna L. Tokics H. Lundquist B. Brismar 《Acta anaesthesiologica Scandinavica》1986,30(3):256-259
In previous studied with computed tomography (CT) prior to and during general anaesthesia, we found that densities developed in dependent parts of the lungs immediately after induction of anaesthesia in all examined patients. It was suggested that the densities were atelectases created by compression of lung tissue but an alternative explanation could be accumulation of extravascular fluid in the lung tissue and/or in the pleural space. In the present study the nature of the densities was analysed in further detail. Injections of contrast medium into the pleural space revealed that the densities were located in the lung tissue and not in the pleural space. By injecting contrast medium intravenously and repeating the CT scanning over a 2-min period the passage of contrast through the major vessels and the lung densities could be studied. The transit time of the contrast medium was of the same magnitude in the densities and the major lung vessels. This indicates that there were no regions with an increased amount of extravascular fluid to delay the contrast passage. These findings oppose the idea of fluid accumulation as the cause of the densities, while atelectasis remains the most plausible explanation. 相似文献